| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.71B | $2.20B | $2.36B |
| YoY Revenue Growth % | -22.6% | -6.6% | — |
| Gross Profit | $353.5M | $533.3M | — |
| Gross Margin % | 20.7% | 24.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $79.8M | $212.1M | $233.3M |
| Operating Margin % | 4.7% | 9.6% | 9.9% |
| Net Income (GAAP) | $72.6M | $196.1M | $199.2M |
| EBITDA (Normalized) | $80.5M | $213.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$140.0M | -$143.7M | -$57.0M |
| Capital Expenditures (CapEx) | $924.0K | $2.0M | — |
| Free Cash Flow (FCF) | -$140.9M | -$145.7M | -$57.0M |
| FCF Margin % | -8.3% | -6.6% | -2.4% |
| Return on Invested Capital (ROIC %) | 3.0% | 8.4% | — |
| Cash & Short-Term Equivalents | — | $53.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $2.10B | $2.04B | — |